Health
Access to cancer medicines and clinical trials show stark variations across Europe – Science Codex
Lugano, Switzerland, 18 September 2020 – Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020. (1,2)
Countries in Western Europe run a higher number of clinical trials for novel cancer treatments than countries in Eastern and Central Europe, showed an an…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General24 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News22 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
Noosa News19 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down